Skip to content
Menu

Harvard Bioscience, Inc. HBIO

Full chart Compare
Set alert

Price alert · HBIO

All alert types
8.66 USD -0.02 (-0.23%)

Regular-session close

8.49 -0.17 -1.96%

After hours · Nov 20, 4:00 PM ET

8.53 Day range 9.00
4.31 52-week range 9.68
YTD
+29.25%
1 year
+54.64%

Held by funds

9 US ETFs and mutual funds hold HBIO · largest positions

  1. VTI 0.00% of fund $865.93K
  2. VXF 0.00% of fund $395.90K
  3. VBINX 0.00% of fund $36.60K
  4. DFSU 0.00% of fund $16.51K
  5. PQSV 0.13% of fund $15.42K
  6. DFAS 0.00% of fund $14.10K
  7. DXUV 0.00% of fund $10.67K
  8. DFAC 0.00% of fund $8.93K
  9. DCOR 0.00% of fund $8.06K

Ownership

  • Institutions 76.0%
  • Insiders 7.77%
  • Public and other holders 16.2%
Held by insiders 7.77%
Held by institutions 75.99%
Float held by institutions 82.39%
Institutions 130

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Blackrock Inc.6.69%2,916,1766.12MSep 29, 2024
Punch & Associates Investment Management, Inc.6.36%2,772,7005.82MSep 29, 2024
Harvey Partners, LLC6.22%2,715,0005.70MSep 29, 2024
AMH Equity Ltd.5.48%2,388,8685.02MSep 29, 2024
Vanguard Group Inc4.94%2,154,0524.52MSep 29, 2024
Granahan Investment Management LLC4.28%1,865,4293.92MSep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.89%1,261,6932.65MSep 29, 2024
Heartland Value Fund2.75%1,200,0002.52MSep 29, 2024
iShares Russell 2000 ETF2.18%952,1212.00MOct 30, 2024
Royce Micro-Cap Fund1.48%647,0171.36MSep 29, 2024
Vanguard Extended Market Index Fund1.33%579,9861.22MSep 29, 2024
JNL Series Trust-JNL/Multi Manager Small Cap GrowthFd1.04%453,803952.99KSep 29, 2024

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Leadership team

Who runs HBIO, and what each was last paid

John Duke, President, CEO, Director & Member of Scientific Advisory Board

HBIO key executives
NameTitlePayAge
John DukePresident, CEO, Director & Member of Scientific Advisory Board$581K 55
Mark T. FrostCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer$426K 63
Kathryn FlynnCorporate Controller— —
David PanzarellaSenior Vice President of Commercial— —
Lori PackerVice President of Global People Operations— —
David SiroisDirector of Corporate Accounting & SEC Reporting— —

Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

HBIO insiders
InsiderRelationLatest transactionDateShares held
COTE JENNIFERChief Financial OfficerStock Award(Grant)Mar 4, 2024168,738
EADE KATHERINE ANNEDirectorStock Award(Grant)May 20, 2024311,126
EDRICK ALAN IANDirectorStock Award(Grant)May 20, 2024273,911
GREEN JAMES WChief Executive OfficerPurchaseJun 12, 20243,111,090
LOEWALD THOMAS WDirectorStock Award(Grant)May 20, 2024295,311
LOY BERTRANDDirectorStock Award(Grant)May 20, 2024556,208